Quidel Corporation

(QDEL) Trade

By |

Profile

Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays.

Contact Information

Website: www.quidel.com
Email: ir@quidel.com
Main Phone: +1 858 552-1100
Address: 12544 High Bluff Drive
Address 2: Suite 200
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: NGS
CEO: Douglas C. Bryant
Employees: 1224
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)

Equities News



Gathering Data... Please wait

Profile

Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays.

Contact Information

Website: www.quidel.com
Email: ir@quidel.com
Main Phone: +1 858 552-1100
Address: 12544 High Bluff Drive
Address 2: Suite 200
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: NGS
CEO: Douglas C. Bryant
Employees: 1224
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)

Equities News

$ 60.57 $ 0. (0.00%)
Last Price 60.57 Change $ 0. Change % 0.00 Tick N/A
Bid 57.92 Bid Size 100.00 Ask 62.65 Ask Size 100.00
Open N/A High N/A Low N/A Prev Close 60.57
Last Trade Volume 1,290 52 Wk Hi 70.31 52 Wk Low 44.27
Market Cap 2.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 41,441,467.00 EPS (TTM) 1.68 PE Ratio 34.90 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 45 200
Number of Buys 32 110
Number of Sells 13 90
Net Activity 29236 91158
Last 10 Buys Shares
Douglas C. Bryant 1,000
Douglas C. Bryant 1,000
Douglas C. Bryant 1,000
Douglas C. Bryant 1,000
Jack W Schuler 1,000
Jack W Schuler 1,000
Jack W Schuler 1,000
Douglas C. Bryant 1,000
John D. Tamerius 1,000
John D. Tamerius 1,000
Last 10 Sell Shares
Douglas C. Bryant 1,000
Douglas C. Bryant 1,000
Douglas C. Bryant 1,000
Thomas D. Brown 1,000
Douglas C. Bryant 1,000
Douglas C. Bryant 1,000
Douglas C. Bryant 1,000
Douglas C. Bryant 1,000
Douglas C. Bryant 1,000
Douglas C. Bryant 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 66 66 66 66
Low Target Price Estimate 48 48 48 48
Mean Target Price Estimate 58 58 58 58
Standard Deviation 8.12 8.12 8.12 8.12
Date of Most Recent Estimate 05/09/18 05/09/18 05/09/18 05/09/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 5
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.5 1.43